Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Bengaluru: Illegally...

    Bengaluru: Illegally imported skin-whitening drugs worth Rs 13.5 lakh recovered

    Written by Ruby Khatun Khatun Published On 2018-05-17T16:30:42+05:30  |  Updated On 17 May 2018 4:30 PM IST
    Bengaluru: Illegally imported skin-whitening drugs worth Rs 13.5 lakh recovered

    It is believed by the investigators that the drug is used for skin bleaching through unethical medical practices in cosmetology clinics and beauty parlours in Bengaluru and other southern cities owing to the huge demand for fairer skin.


    BENGALURU: Illegally imported skin whitening drugs have been detained by the Directorate of Revenue Intelligence (DRI) in Bengaluru helping the agency to reveal a huge racket involved in smuggling the cosmetology drugs in the state for use and distribution in all parts of the southern states, according to a recent media report.


    TOI reports that DRI has apprehended skin-whitening powder worth over Rs 13.5 lakh that are illegally imported in the state. It is believed by the investigators that the drug is used for skin bleaching through unethical medical practices in cosmetology clinics and beauty parlours in Bengaluru and other southern cities owing to the huge demand for fairer skin.


    Sources with DRI’s Bengaluru zonal unit believe the city has increasingly become the receiving and distribution point for skin whitening drugs shipped from Thailand and Malaysia due to rising demand for skin treatments.


    An investigating officer told TOI, “In the second week of May, we received a tip-off that a large consignment of skin-whitening medicines was being dropped off at a house in Jaynagar.”


    On May 8 investigating officers caught a man that has arrived at the location to receive 100 cartons that were sent from Bangkok to Bengaluru. The cartons were misleadingly declared as food supplements.


    The officer added, “We caught the man and an inspection of the cartons revealed numerous bottles of Japan-made Tatio Active DX Powder. It was known that the powder was meant to be administered into the body through intravenous injections, popularly known as drip.”


    Special food supplements are often not opened and inspected in India due to expiry deadlines for food items. Legal importing of the skin-whitening drug requires the approval of the drugs control department.

    The investigators have held another man related to the incident. Both the suspects are from Bhatkal and had come to Bengaluru to pick up the consignment.


    As per the news report, the suspects have also revealed that they had similarly imported over 1,000 such boxes of the medicine valued at more than Rs 1.35 crore on earlier occasions.


    “We suspect more gangs could be involved in this illegal drug trade. They use Bengaluru as a receiving point and send the drugs to Chennai, Kochi, and Hyderabad. We suspect the drug is illegally given to clients through some clinics and beauty parlours,” another DRI official told TOI.


    Anil Abrahamcosmetology drugsDirectorate of Revenue IntelligenceDRIillegally importedintravenous injectionsseizedskin-whitening drugssmugglingTatio Active DX Powder
    Source : With Inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok